{
  "id": 521,
  "text": "# SYSTEMIC THERAPYFOR CERVICALCANCERa <html><body><table><tr><td colspan=\"3\">Small Cell NECC!</td></tr><tr><td rowspan=\"2\">Chemoradiationm</td><td colspan=\"2\">Recurrent or Metastatic Disease</td></tr><tr><td>First-line Therapyf Preferred Regimens</td><td>Second-line or Subsequent Therapy Other Recommended Regimens</td></tr><tr><td>Preferred Regimens Other Recommended Regimens · Carboplatin + etoposide if patient is cisplatin intolerant' ·Cisplatin + etoposidel222</td><td>· Cisplatin/etoposide · Carboplatin/etoposide Other Recommended Regimens ·Cisplatin/etoposide+atezolizumab</td><td>·Bevacizumab9 · Albumin-bound paclitaxel · Docetaxel · Topotecan ·Topotecan/paclitaxel</td></tr></table></body></html> # 指南重点内容 !",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: # SYSTEMIC THERAPYFOR CERVICALCANCERa <html><body><table><tr><td colspan=\"3\">Small Cell NECC!</td></tr><tr><td rowspan=\"2\">Chemoradiationm</td><td colspan=\"2\">Recurrent or Metastatic Disease</td></tr><tr><td>First-line Therapyf Preferred Regimens</td><td>Second-line or Subsequent Therapy Other Recommended Regimens</td></tr><tr><td>Preferred Regimens Other Recommended Regimens · Carboplatin + etopo\n\n<question>: ",
  "ChatGPT_response_0": "子宫颈癌的系统治疗方案通常包括化疗和放疗的组合，特别是对于复发或转移性疾病。一线治疗方案常见的包括卡铂+依托泊苷或顺铂+依托泊苷。对于不能耐受顺铂的患者，可以考虑卡铂+依托泊苷的方案。对于复发或进展性子宫颈癌，可以考虑二线或后续治疗，包括顺铂/依托泊苷、卡铂/依托泊苷等方案。此外，还有其他推荐的治疗方案，如顺铂/依托泊苷+阿特朱单抗。在选择治疗方案时，应充分考虑患者的个体情况和遗传特征，以制定最合适的治疗计划。",
  "query": "什么是子宫颈癌的系统治疗方案？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 什么是子宫颈癌的系统治疗方案？\n\n<reference text>: # SYSTEMIC THERAPYFOR CERVICALCANCERa <html><body><table><tr><td colspan=\"3\">Small Cell NECC!</td></tr><tr><td rowspan=\"2\">Chemoradiationm</td><td colspan=\"2\">Recurrent or Metastatic Disease</td></tr><tr><td>First-line Therapyf Preferred Regimens</td><td>Second-line or Subsequent Therapy Other Recommended Regimens</td></tr><tr><td>Preferred Regimens Other Recommended Regimens · Carboplatin + etoposide if patient is cisplatin intolerant' ·Cisplatin + etoposidel222</td><td>· Cisplatin/etoposide · Carboplatin/etoposide Other Recommended Regimens ·Cisplatin/etoposide+atezolizumab</td><td>·Bevacizu\n\n<reply>: ",
  "response": "子宫颈癌的系统治疗方案通常包括化疗和放疗的组合，特别是对于复发或转移性疾病。一线治疗方案常见的包括卡铂+依托泊苷或顺铂+依托泊苷。对于不能耐受顺铂的患者，可以考虑卡铂+依托泊苷的方案。对于复发或进展性子宫颈癌，可以考虑二线或后续治疗，包括顺铂/依托泊苷、卡铂/依托泊苷等方案。此外，还有其他推荐的治疗方案，如顺铂/依托泊苷+阿特朱单抗。在选择治疗方案时，应充分考虑患者的个体情况和遗传特征，以制定最合适的治疗计划。"
}